Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder

Archives of General Psychiatry

Volumn 65, Issue 5, 2008, Pages 551-562

  Pollack, Mark ^a   Kinrys, Gustavo ^b,c   Krystal, Andrew ^d   McCall, W Vaughn ^e   Roth, Thomas ^f   Schaefer, Kendyl ^g   Rubens, Robert ^g   Roach, James ^g   Huang, Holly ^g   Krishnan, Ranga ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CAMBRIDGE HEALTH ALLIANCE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^f HENRY FORD HOSPITAL   (United States)

^g SUNOVION PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; ESZOPICLONE;

ADD ON THERAPY; ADULT; ARTICLE; ASTHMA; BACKACHE; BEDTIME DOSAGE; CHOLELITHIASIS; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG OVERDOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HEADACHE; HUMAN; INSOMNIA; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; PREDICTION; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHINOPHARYNGITIS; SINGLE BLIND PROCEDURE; SLEEP; SOMNOLENCE; SORE THROAT; TASTE DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; XEROSTOMIA;

ADOLESCENT; ADULT; ANXIETY DISORDERS; AZABICYCLO COMPOUNDS; CITALOPRAM; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PIPERAZINES; SEROTONIN UPTAKE INHIBITORS; SINGLE-BLIND METHOD; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 43149106481     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.65.5.551     Document Type: Article

References (48)

1. Silber MH. Clinical practice: chronic insomnia. N Engl J Med. 2005;353(8):803-810.
2. Stein MB. Public health perspectives on generalized anxiety disorder. J Clin Psychiatry. 2004;65(suppl 13):3-7.
3. Papadimitriou GN, Kerkhofs M, Kempenaers C, Mendlewicz J. EEG sleep studies in patients with generalized anxiety disorder. Psychiatry Res. 1988;26(2):183-190.
4. Stein MB, Mellman TA. Anxiety disorders. In: Kryger M, Guilleminault C, eds. Principles and Practice of Sleep Medicine. 4th ed. Baltimore, MD: Elsevier Saunders; 2005:1297-1310.
5. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res. 1997;31(3):333-346.
6. Monti JM, Monti D. Sleep disturbance in generalized anxiety disorder and its treatment. Sleep Med Rev. 2000;4(3):263-276.
7. Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res. 2003;37(1):9-15.
8. Wetherell JL, Le RH, Gatz M. DSM-IV criteria for generalized anxiety disorder in older adults: distinguishing the worried from the well. Psychol Aging. 2003;18(3):622-627.
9. Kelly WE. Worry and sleep length revisited: worry, sleep length, and sleep disturbance ascribed to worry. J Genet Psychol. 2002;163(3):296-304.
10. Kelly WE. Worry content associated with decreased sleep-length among college students. Coll Stud J. 2003;37:93-95.
11. Kales JD, Kales A, Bixler EO, Soldatos CR, Cadieux RJ, Kashurba GJ, Vela-Bueno A. Biopsychobehavioral correlates of insomnia, V: clinical characteristics and behavioral correlates. Am J Psychiatry. 1984;141(11):1371-1376.
12. Saletu-Zyhlarz G, Saletu B, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L. Nonorganic insomnia in generalized anxiety disorder, 1: controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology. 1997;36(3):117-129.
13. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders: a meta-analysis. Arch Gen Psychiatry. 1992;49(8):651-668.
14. Fuller KH, Waters WF, Binks PG, Anderson T. Generalized anxiety and sleep architecture: a polysomnographic investigation. Sleep. 1997;20(5):370-376.
15. Arriaga F, Paiva T. Clinical and EEG sleep changes in primary dysthymia and generalized anxiety: a comparison with normal controls. Neuropsychobiology. 1990;24(3):109-114.
16. Reynolds CF III, Shaw DH, Newton TF, Coble PA, Kupfer DJ. EEG sleep in outpatients with generalized anxiety: a preliminary comparison with depressed outpatients. Psychiatry Res. 1983;8(2):81-89.
17. Papadimitriou GN, Linkowski P, Kerkhofs M, Kempenaers C, Mendlewicz J. Sleep EEG recordings in generalized anxiety disorder with significant depression. J Affect Disord. 1988;15(2):113-118.
18. Papadimitriou GN, Linkowski P. Sleep disturbance in anxiety disorders. Int Rev Psychiatry. 2005;17(4):229-236.
19. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989;262(11):1479-1484.
20. Johnson EO, Roth T, Breslau N. The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res. 2006;40(8):700-708.
21. Mendelson WB. Effects of flurazepam and zolpidem on the perception of sleep in insomniacs. Sleep. 1995;18(2):92-96.
22. National Institutes of Health Consensus Development Conference Statement: the treatment of sleep disorders of older people. Sleep. 1990;14(2):169-177.
23. National Institutes of Health. National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep. 2005;28(9):1049-1057.
24. Nowell PD, Buysse DJ. Treatment of insomnia in patients with mood disorders. Depress Anxiety. 2001;14(1):7-18.
25. Asnis GM, Chakraburtty A, DuBoff EA, Krystal A, Londborg PD, Rosenberg R, Roth-Schechter B, Scharf MB, Walsh JK. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry. 1999;60(10):668-676.
26. Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006;59(11):1052-1060.
27. Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep. 2003;26(7):793-799.
28. Zammit GK, McNabb L, Caron J, Amato D, Roth T. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin. 2004;20(12):1979-1991.
29. Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med. 2005;6(6):487-495.
30. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33.
31. Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes. 2003;1(1):29.
32. HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-55.
33. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
34. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
35. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297-307.
36. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire. Psychopharmacol Bull. 1993;29(2):321-326.
37. Sheehan DV, Ballenger J, Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry. 1980;37(1):51-59.
38. Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs. 2005;65(7):927-947.
39. Davidson JR, Bose A, Korotzer A, Zheng H. Escitalopram in the treatment of generalized anxiety disorder. Depress Anxiety. 2004;19(4):234-240.
40. Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. Am J Psychiatry. 2004;161(9):1642-1649.
41. Fontaine R, Beaudry P, Le MP, Beauclair L, Chouinard G. Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. Int Clin Psychopharmacol. 1990;5(3):173-183.
42. Agnoli A, Manna V, Martucci N. Double-blind study on the hypnotic and antianxiety effects of zopiclone compared with nitrazepam in the treatment of insomnia. Int J Clin Pharmacol Res. 1989;9(4):277-281.
43. Soares CN, Joffe H, Rubens R, Caron J, Roth T, Cohen L. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol. 2006;108(6):1402-1410.
44. Steiner M, Allgulander C, Ravindran A, Kosar H, Burt T, Austin C. Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder. Hum Psychopharmacol. 2005;20(1):3-13.
45. Simon NM, Zalta AK, Worthington JJ III, Hoge EA, Christian KM, Stevens JC, Pollack MH. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder. Depress Anxiety. 2006;23(6):373-376.
46. Kornstein SG, Sloan DM, Thase ME. Gender-specific differences in depression and treatment response. Psychopharmacol Bull. 2002;36(4)(suppl 3):99-112.
47. Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord. 1997;42(2-3):209-212.
48. Asnis G, Shrivastava R, Lydiard B, Bastania B, Sheehan D, Roth T, Fava M. Improved insomnia symptoms, quality of life, and daily functioning in patients with comorbid generalized anxiety disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment [abstract]. ACCP 2007 Annual Meeting Guide and Abstracts. http://www.pharmacotherapy.org/ pdf/free/ACCP_Abstracts_Fall2007.pdf Accessed November 20, 2007.